Histamine in murine narcolepsy: What do genetic and immune models tell us?


Journal

Brain pathology (Zurich, Switzerland)
ISSN: 1750-3639
Titre abrégé: Brain Pathol
Pays: Switzerland
ID NLM: 9216781

Informations de publication

Date de publication:
03 2022
Historique:
revised: 14 09 2021
received: 27 05 2021
accepted: 27 09 2021
pubmed: 22 10 2021
medline: 6 5 2022
entrez: 21 10 2021
Statut: ppublish

Résumé

An increased number of histaminergic neurons, identified by labeling histidine-decarboxylase (HDC) its synthesis enzyme, was unexpectedly found in patients with narcolepsy type 1 (NT1). In quest for enlightenment, we evaluate whether an increase in HDC cell number and expression level would be detected in mouse models of the disease, in order to provide proof of concepts reveling possible mechanisms of compensation for the loss of orexin neurons, and/or of induced expression as a consequence of local neuroinflammation, a state that likely accompanies NT1. To further explore the compensatory hypothesis, we also study the noradrenergic wake-promoting system. Immunohistochemistry for HDC, orexin, and melanin-concentrating hormone (MCH) was used to count neurons. Quantitative-PCR of HDC, orexin, MCH, and tyrosine-hydroxylase was performed to evaluate levels of mRNA expression in the hypothalamus or the dorsal pons. Both quantifications were achieved in genetic and neuroinflammatory models of narcolepsy with major orexin impairment, namely the orexin-deficient (Orex-KO) and orexin-hemagglutinin (Orex-HA) mice respectively. The number of HDC neurons and mRNA expression level were unchanged in Orex-KO mice compared to controls. Similarly, we found no change in tyrosine-hydroxylase mRNA expression in the dorsal pons between groups. Further, despite the presence of protracted local neuroinflammation as witnessed by the presence of reactive microglia, we found no change in the number of neurons nor the expression of HDC in Orex-HA mice compared to controls. Importantly, no correlation was found in all conditions between HDC and orexin. Our findings indicate that, in mice, the expression of histamine and noradrenalin, two wake-promoting systems, are not modulated by orexin level whether the lack of orexin is constitutive or induced at adult age, showing thus no compensation. They also show no recruitment of histamine by local neuroinflammation. Further studies will be needed to further define the role of histamine in the pathophysiology of NT1.

Identifiants

pubmed: 34672414
doi: 10.1111/bpa.13027
pmc: PMC8877734
doi:

Substances chimiques

Orexins 0
RNA, Messenger 0
Histamine 820484N8I3
Mixed Function Oxygenases EC 1.-
Histidine Decarboxylase EC 4.1.1.22

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13027

Informations de copyright

© 2021 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.

Références

Nat Med. 2000 Sep;6(9):991-7
pubmed: 10973318
Brain Pathol. 2003 Jul;13(3):340-51
pubmed: 12946023
Brain Behav Immun. 2015 Oct;49:54-8
pubmed: 25771509
J Comp Neurol. 2006 Oct 10;498(5):667-89
pubmed: 16917819
Neuron. 2005 Jun 2;46(5):787-98
pubmed: 15924864
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12323-E12332
pubmed: 30541895
Sleep. 2009 Aug;32(8):993-8
pubmed: 19725250
J Neurosci. 1998 Dec 1;18(23):9996-10015
pubmed: 9822755
Curr Top Behav Neurosci. 2017;33:51-74
pubmed: 27830577
Front Neurosci. 2021 May 20;15:660518
pubmed: 34093114
J Neuroinflammation. 2020 Jun 15;17(1):187
pubmed: 32539736
Nat Rev Neurol. 2015 Jul;11(7):401-13
pubmed: 26100750
Nature. 2018 Oct;562(7725):63-68
pubmed: 30232458
J Neurosci. 2014 May 7;34(19):6495-509
pubmed: 24806676
Sleep. 2009 Feb;32(2):175-80
pubmed: 19238804
Neurology. 2009 Aug 18;73(7):511-7
pubmed: 19687452
J Neurosci. 1981 Aug;1(8):876-86
pubmed: 7346592
PLoS One. 2012;7(3):e33723
pubmed: 22470463
Agents Actions. 1984 Apr;14(3-4):554-7
pubmed: 6731185
Brain Pathol. 2022 Mar;32(2):e13027
pubmed: 34672414
Nat Commun. 2019 Feb 19;10(1):837
pubmed: 30783092
J Comp Neurol. 2007 Nov 10;505(2):147-57
pubmed: 17853446
Brain Behav Immun. 2009 Oct;23(7):926-30
pubmed: 19328847
CNS Drugs. 2017 Oct;31(10):821-834
pubmed: 28940143
Ann Neurol. 2013 Dec;74(6):794-804
pubmed: 24006291
J Clin Invest. 2010 Mar;120(3):713-9
pubmed: 20160349
Neuron. 2000 Sep;27(3):469-74
pubmed: 11055430
Elife. 2016 Dec 30;5:
pubmed: 28035899
Brain Behav Immun. 2014 Mar;37:260-6
pubmed: 24394344
Arch Neurol. 2002 Oct;59(10):1553-62
pubmed: 12374492
Gen Comp Endocrinol. 2014 Apr 1;199:86-93
pubmed: 24472706
Front Cell Neurosci. 2018 Apr 24;12:110
pubmed: 29755322
Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):10956-61
pubmed: 27621438
J Autoimmun. 2015 Jun;60:20-31
pubmed: 25892508
Nat Rev Neurol. 2019 Sep;15(9):519-539
pubmed: 31324898
Curr Pharm Des. 2016;22(7):819-48
pubmed: 26648474
PLoS One. 2015 Apr 10;10(4):e0124047
pubmed: 25861024
Neurosci Lett. 2014 Jun 6;570:47-52
pubmed: 24708924
Brain Res. 1999 Sep 4;840(1-2):138-47
pubmed: 10517961
Curr Biol. 2014 Dec 1;24(23):2838-44
pubmed: 25454592
J Neuroinflammation. 2019 Mar 20;16(1):64
pubmed: 30894198
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E368-77
pubmed: 26668381
J Neurosci. 2005 Jul 13;25(28):6716-20
pubmed: 16014733
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2635-44
pubmed: 22955882
Sleep. 2009 Aug;32(8):979-83
pubmed: 19725248
Sleep. 2021 Jul 9;44(7):
pubmed: 33476396
Brain Res Mol Brain Res. 1998 Jun 1;57(1):1-9
pubmed: 9630473
Sleep. 2010 Nov;33(11):1428-30
pubmed: 21102981
Neuron. 2001 May;30(2):345-54
pubmed: 11394998
PLoS One. 2013 Jul 01;8(7):e69123
pubmed: 23840908
Ann Neurol. 2013 Dec;74(6):786-93
pubmed: 23821583
Sleep. 2012 Oct 01;35(10):1359-66
pubmed: 23024434
CNS Neurosci Ther. 2019 Mar;25(3):386-395
pubmed: 30225986
Brain Res. 2004 Sep 3;1019(1-2):162-9
pubmed: 15306250
Neuron. 2017 Feb 22;93(4):747-765
pubmed: 28231463
J Neurosci. 2004 Jul 28;24(30):6760-4
pubmed: 15282280

Auteurs

Silvia Melzi (S)

Sleep Team, Center for Research in Neuroscience of LYON, CNRS UMR5292, INSERM U1028, University of Lyon1, Bron, France.

Anne-Laure Morel (AL)

Sleep Team, Center for Research in Neuroscience of LYON, CNRS UMR5292, INSERM U1028, University of Lyon1, Bron, France.

Céline Scoté-Blachon (C)

Functional Neurogenetics platform, Center for Research in Neuroscience of LYON, CNRS UMR5292, INSERM U1028, University of Lyon1, Bron, France.

Roland Liblau (R)

Toulouse Institute for Infectious and Inflammatory diseases, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, UPS, University of Toulouse, Toulouse, France.

Yves Dauvilliers (Y)

National Reference Centre for Orphan Diseases, Narcolepsy - Rare hypersomnia, Sleep Unit, Department of Neurology, CHU Montpellier, Institute for Neuroscience of Montpellier INM, INSERM U1298, University of Montpellier, Montpellier, France.

Christelle Peyron (C)

Sleep Team, Center for Research in Neuroscience of LYON, CNRS UMR5292, INSERM U1028, University of Lyon1, Bron, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH